Thomas Umbel

Tom Umbel has been the President and CEO of Seno Medical since January of 2016. Tom led the Business Development efforts at Hologic, the largest dedicated Women’s Health company in the U.S. Tom’s role in managing mergers and acquisitions helped grow Hologic from a small single-product company with $100 million in revenue to a large, diversified company with more than $2.5 billion during his 15 years. Among his Hologic accomplishments, he led the acquisition of Cytyc ($6.6 billion) and GenProbe. Prior to Hologic, Tom was President of Direct Radiography Corp. (DRC). He led the development and commercialization of the digital x-ray detector technology, which he ultimately sold to Hologic in 1999. This core market-leading digital mammography system is their engine to significant growth. Tom continues to serve on many medical device and diagnostic company boards. Tom holds a BS Science degree in chemical engineering from Grove City College.